MENU
SER
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Serina Therapeutics (SER) Ownership - Who owns Serina Therapeutics?
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain... Show more
Profile
Industry
N/A
Address
601 Genome Way
Phone
+1 256 327-0566
Employees
N/A
Web
https://www.serinatherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
61.5M
P/E Ratio
1.83
Total Cash
4.27M
Projected Growth
N/A
Total Debt
227K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.43
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SER
Capitalization
61.5M
P/E Ratio
1.83
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
4.27M
Total Cash/Share
0.43
Total Debt
227K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.7M
P/B Ratio
36.10
Cash Flow
N/A
Earnings
3.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
2.45
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-488K
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-10.68
Shares Held By Institutions
2.45M
Shares Outstanding - Current
9.97M
Total Liabilities
5.17M
Total Volume MTD
N/A
Value
-1
Gain YTD
23.154
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
601 Genome Way
Phone
+1 256 327-0566
Employees
N/A
Web
https://www.serinatherapeutics.com